Evaluation of Dopaminergic Denervation by DaTSCAN Brain Scintigraphy Using a New Multipurpose CZT System (STARDAT)
Clinical Evaluation of a New Multipurpose Whole-body CZT Camera in DaTSCAN Brain Scintigraphy: a Head-to-head Comparison With a Conventional System.
Sponsor: Centre Hospitalier Régional d'Orléans
Terminated
As the team at Nancy University Hospital published the same study last year, on the competing CZT 3D system (Veriton), our study is no longer relevant.
Other terminated trials from Centre Hospitalier Régional d'Orléans
- Stroke, Acute · Phase NA · Aug 2024
- Hypovolemia · Phase NA · May 2024
- COVID-19 · Phase NA · Mar 2023
- Muscle Weakness · Phase NA · Dec 2021
- Spouse Abuse · Jul 2021
See all terminations from Centre Hospitalier Régional d'Orléans
Other Parkinson Disease trials with similar outcome
This NA trial investigates Parkinson Disease and is currently terminated or withdrawn. Centre Hospitalier Régional d'Orléans leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Feb 2024 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Feb 2023 — Feb 2024 [monthly]
Recruiting NA
-
Sep 2022 — Feb 2023 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Sep 2021 — Sep 2022 [monthly]
Recruiting NA
First recorded
Apr 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Régional d'Orléans
For direct contact, visit the study record on ClinicalTrials.gov .